and Washington, D.C. (October 19, 2005) -- Boston Scientific Corporation (NYSE: BSX) was recognized by physicians as a leader in the pursuit of evidence-based medicine through increased use of randomized controlled clinical trials. The comments were made during the annual Transcatheter Cardiovascular Therapeutics symposium, in Washington, D.C. The clinical program supporting the Company